Russia registers new Covid-19 drug to keep complication caused by virus ‘under control'
Added 06-07-20 01:37:02am EST - “Russian developers have registered a new drug against the coronavirus that is supposed to deal with the harshest complications caused by Covid-19, including lung failure, and buy time before the vaccine is made.” - Rt.com
CLICK TO SHARE
Levilimab is the second drug to receive state approval through a fast-track mechanism, implemented to give doctors more means to tackle the virus, which already infected more than 459,000 and killed 5,725 in Russia.
“I think we’ll be able to keep Covid-19 complications under control and minimize the harshest problems it causes,” Dmitry Morozov, general director of Biocad, the biopharmaceutical company behind the drug, wrote on Facebook.
The drug is aimed at curbing the so-called ‘cytokine storm,’ a common complication from Covid-19 when the sick person’s immune system overreacts to the virus and the excessive inflammatory leads to fatal outcome.
“The mechanism [used in Levilimab] is known to researchers around the globe. But all the rest was done in Russia, by out company, from scratch. There’s an original patented molecule," Morozov told RT.
Levilimab’s highlight is that it can be administered not only to patients already in a serious condition, but used as a prophylactic to “prevent the ‘cytokine storm’ from occurring and allowing the patient to avoid intensive care and lung ventilation,” he pointed out.
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE